Highlights CKD Corporation

Equities

6407

JP3346800000

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
2,962 ^JPY	-0.17%		+3.49%	+16.61%

Apr. 15	AstraZeneca: expects a sharp rise in kidney disease	CF
Apr. 11	TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca: expects a sharp rise in kidney disease	Apr. 15	CF
TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000	Apr. 11	MT
Final dividend	Mar. 27	FA
Novo Nordisk: EU could authorize Wegovy by April	Feb. 23	CF
Novo Nordisk: EU authorization for Wegovy by April?	Feb. 23	CF
Disc Medicine Says FDA Grants Fast Track Designation for Investigational Treatment of Chronic Kidney Disease, Anemia	Feb. 20	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	Jan. 31	MT
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19	MT
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19	MT
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease	Jan. 03	MT
Hansoh Pharma's Three Drugs Added to China’s National Reimbursement Drug List	Dec. 14	MT
AstraZeneca discontinues two phase III evidence trials for Lokelma	Dec. 01	AN
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	Nov. 30	MT
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis	Nov. 08	MT
US FDA approves Ardelyx's kidney disease-related drug	23-10-17	RE
Novo Nordisk in $1.3 bln deal to buy hypertension drug	23-10-16	RE
Ex-dividend day for interim dividend	23-09-27	FA
Eli Lilly, Boehringer Ingelheim Say US FDA Approved Jardiance Tablets to Treat Adults With Chronic Kidney Disease	23-09-22	MT
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH	23-09-06	MT
Renalytix hails KidneyIntelX inclusion in guidance to evaluate CKD	23-08-21	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CKD Corporation

Equities

6407

JP3346800000

Highlights

Filters